Brunn Carsten — SEC Form 4 filings

SEC reporting owner CIK 1760229. 4 Form 4 filings on record with FilingPulse; latest filed 2026-01-08.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2025-01-06 to 2026-01-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Cartesian Therapeutics, Inc. (RNAC)President and CEO, Director43 legs · 41,037 sh · $451,8414

Form 4 filings — Brunn Carsten

FiledFormIssuerReported transactionsSource
2026-01-084Cartesian Therapeutics, Inc. (RNAC)Sale (S): 23,766 @ $6.82EDGAR
2026-01-064Cartesian Therapeutics, Inc. (RNAC)Grant/award (A): 143,200 @ $0 · Grant/award (A): 415,700 (derivative) @ $0EDGAR
2025-01-074Cartesian Therapeutics, Inc. (RNAC)Sale (S): 8,563 @ $16.72 · Sale (S): 8,708 @ $16.83EDGAR
2025-01-064Cartesian Therapeutics, Inc. (RNAC)Grant/award (A): 57,500 @ $0 · Grant/award (A): 169,100 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1760229 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →